US 9555016
Lytic agents for use in treating intravascular clots
granted A61KA61K31/155A61K47/02
Quick answer
US patent 9555016 (Lytic agents for use in treating intravascular clots) held by Covidien LP expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Covidien LP
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/155, A61K47/02, A61K9/0019, A61K9/08